DNA-scaffolded biomaterials enable modular and tunable control of cell-based cancer immunotherapies
X. Huang, J. Z. Williams, R. Chang, Z. Li, E. Gai, D. M. Patterson, W. Yu, W. A. Lim, T. A. Desai
The paper develops a biomaterial platform to control immune cell activity by modulating protein ratios on biodegradable particles, enhancing cancer immunotherapy efficacy and safety.
bioRxiv · Mar 23, 2019 · PreprintBioengineering